Taiwan has begun administering its first locally-created COVID-19 vaccine Medigen amid criticisms. President Tsai Ing-wen approved the distribution by receiving the first shot. The country’s health ministry granted authority to the emergency use of the vaccine last month despite not having completed phase three trials yet. The company assures that the vaccine has no major safety concerns and the antibodies made are “no worse than” the shots created by AstraZeneca.

The country’s vaccination efforts were hindered due to delayed delivery and hesitancy among its people. Opposition party Kuomintang (KMT) accuses the vaccine as unsafe and was introduced too early in the market. Two members of the party sought a court to revoke the approval due to inadequate testing. Nonetheless, more than 700,000 citizens signed up for the Medigen vaccine. It requires a second dose 28 days after the first shot. The government has ordered five million doses but has declared that it will not force the people to get the vaccine. Less than 5% of Taiwan’s population of 23.5 million are fully vaccinated, and about 40% are yet to receive the second dose.